MyMD Pharmaceuticals Inc. buy Quitte
Start price
04.06.18
/
50%
€169.72
Target price
07.11.18
€242.46
Performance (%)
-36.53%
End price
07.11.18
€107.72
Summary
This prediction ended on 07.11.18 with a price of €107.72. The BUY prediction by Quitte for MyMD Pharmaceuticals Inc. performed very badly with a performance of -36.53%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MyMD Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by Quitte for this prediction
In the thread MyMD Pharmaceuticals Inc. diskutieren
nach dem Tiefschlag ist vor dem Anstieg
zumindest mit einer kurzfristigen Erholung ist vermutlich zu rechen
https://seekingalpha.com/news/3359914-akers-bio-34-percent-premarket-withdrawal-u-s-marketing-application-chlamydia-test
(Vom Mitglied beendet)